Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced the publication of a study in the Journal of Interferon & Cytokine Research by scientists at Alnylam Europe (now Roche Kulmbach), and [...]

Continue reading " Alnylam and Collaborators Publish Research on the Immunostimulatory Properties and Mechanisms of Certain siRNAs in Mammalian Cells "